Lumos Pharma, Inc. (LUMO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 25.9M |
| Enterprise Value | -8.59M |
| P/E Ratio | -1.04 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 18.3 |
| Price/Book Ratio | 1.29 |
| Enterprise/Revenue | 1.48 |
| Enterprise/EBITDA | -0.08 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | -16.59 |
| Operating Margin | -17.85 |
AD
Management Effectiveness
| Return On Assets | -0.84 |
| Return On Equity | -0.78 |
Income Statement
| Revenue | 2.05M |
| Revenue/Share | 0.25 |
| Gross Profit | 2.05M |
| EBITDA | -36.57M |
| Net Income | -34.03M |
| Diluted EPS | -4.18 |
Balance Sheet
| Total Cash | 13.52M |
| Total Cash/Share | 4.43 |
| Total Debt | 172,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.69 |
| Book Value Per Share | 3.35 |
Price History
| 52-Week Change | 40.91 |
| 52-Week High | 4.58 |
| 52-Week Low | 1.37 |
| Moving Average 50 Days | 4.23 |
| Moving Average 200 Days | 3.1 |
Statistics
| Average Volume | 102,979 |
| Shares Outstanding | 8.65M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | March 19, 2020 |
AD
